MarkNtel Advisors recently published a detailed industry analysis of the Cell & Gene Therapy Drug Delivery Devices Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
Insights and Analysis of the Cell & Gene Therapy Drug Delivery Devices Market (2023-2028)
The Global Cell & Gene Therapy Drug Delivery Devices Market is anticipated to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28, says MarkNtel Advisors.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html
What is driving the Cell & Gene Therapy Drug Delivery Devices Market?
The factors that are projected to drive the market in the coming years include the following:
- Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies
- Mounting prevalence of genetic disorders & chronic diseases
- An increasing number of FDA approvals for cell & gene therapies & their clinical trials
What segments define the Cell & Gene Therapy Drug Delivery Devices market from 2023 to 2028? How do these segments contribute to market dynamics and growth?
By Product Type
(Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe (Size 1.0 ML, 31-Gauge Needle), (Size 0.5 ML, 22-Gauge Needle)), Pre-Filled Syringe (Size 1.0 ML, 22-26 Gauge Needle), (Size 4.0 ML, 22-26 Gauge Needle)), Infusion Bags (Size 10 ML to 50 ML), (Size 68 ML), (Size 60 ML), (Size Up to 65 ML)),
By Technology
(Microchip Technology, Nano-Technology, Lipid Nanoparticles),
By Commercialized Drugs
(Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis),
By End-Users
(Pharmaceuticals & Biotechnology Company, Academic & Research Institute, Hospitals & Clinics)
By Region
(North America, South America, Europe, APAC, Middle East, Africa)
Explore the Complete Cell & Gene Therapy Drug Delivery Devices Market Analysis Report – https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html
Who are the leading key players shaping the Cell & Gene Therapy Drug Delivery Devices Market landscape?
Amgen Inc., Bausch & Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio Inc., Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.), Dendreon Pharmaceuticals LLC, Helixmith Co. Ltd (ViroMed Co., Ltd), Human Stem Cells Institute, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer Inc., Renova Therapeutics, Spark Therapeutics Inc., uniQure N.V., Vericel Corporation
Questions Addressed in this Study
1.What factors are driving the Cell & Gene Therapy Drug Delivery Devices Market growth?
2.How is the Cell & Gene Therapy Drug Delivery Devices Market expected to grow over the next five years?
3.What are the key insights into the current trends in the Cell & Gene Therapy Drug Delivery Devices Market?
4.What is the current size of the Cell & Gene Therapy Drug Delivery Devices Market, and how is it projected to change in the future?
6.What is the future outlook for the Cell & Gene Therapy Drug Delivery Devices Market in terms of technological advancements and market expansion?
For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/cell-gene-therapy-drug-delivery-devices-market.html
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: [email protected]
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
